CHAMPIONS ONCOLOGY, INC. (CSBR) Operating cash flow 2017–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$4.5MFY2026 · since FY2017: -$2.8M → -$4.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$4.5M | -160.5% |
| FY2025 | $7.4M | +220.4% |
| FY2024 | -$6.1M | -254.5% |
| FY2023 | $4.0M | -38.9% |
| FY2022 | $6.5M | +486.5% |
| FY2021 | -$1.7M | -157.9% |
| FY2020 | $2.9M | +56.0% |
| FY2019 | $1.9M | +251.9% |
| FY2018 | -$1.2M | +56.8% |
| FY2017 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Gross marginCSBR Operating incomeCSBR Operating marginCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →